Sunday, May 31, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Business | Natco Pharma Board Okays Acquiring 1 In Canadian Arm

Natco Pharma board okays acquiring 1% in Canadian arm

Stocks of Natco Pharma were trading 0.74 per cent lower at Rs 810.85 apiece on BSE. 

By PTI
Published Date - 26 March 2021, 05:56 PM
Natco Pharma board okays acquiring 1% in Canadian arm
whatsapp facebook twitter telegram

New Delhi: Drug major Natco Pharma on Friday said its board has approved acquiring about 1 per cent stake in its Canadian subsidiary.

The company, however, did not disclose the value of the deal. “The board of directors of the company at their meeting approved to acquire 0.96 per cent stake in Natco Pharma (Canada) Inc., after this acquisition Natco Pharma (Canada) Inc., (will) become a wholly owned subsidiary company of Natco Pharma Ltd,” Hyderabad-based Natco Pharma said in a regulatory filing.


The company did not share any more details. Stocks of Natco Pharma were trading 0.74 per cent lower at Rs 810.85 apiece on BSE.

  • Follow Us :
  • Tags
  • Canadian subsidiary
  • Hyderabad-based Natco Pharma
  • Natco Pharma
  • regulatory filing

Related News

  • Hyderabad-based Natco Pharma, Hetero Labs, Dr Reddy’s arm bag generic drug contracts in China

    Hyderabad-based Natco Pharma, Hetero Labs, Dr Reddy’s arm bag generic drug contracts in China

  • Hyderabad-based Natco Pharma offers to acquire nearly 36 per cent stake in Adcock Ingram in Rs 2,100-crore deal

    Hyderabad-based Natco Pharma offers to acquire nearly 36 per cent stake in Adcock Ingram in Rs 2,100-crore deal

  • Hyderabad-based Natco Pharma shares crash 19 per cent on poor financial results

    Hyderabad-based Natco Pharma shares crash 19 per cent on poor financial results

  • Hyderabad-based Natco Pharma gets FDA approval for marketing Bosentan Tablets in the United States

    Hyderabad-based Natco Pharma gets FDA approval for marketing Bosentan Tablets in the United States

Latest News

  • Vinesh Phogat’s comeback bid ends in semifinal heartbreak

    3 hours ago
  • Manu Bhaker, Samrat Rana clinch silver in ISSF World Cup Rifle/Pistol

    3 hours ago
  • Anastasia Potapova stuns Coco Gauff to end French Open title defense

    3 hours ago
  • PSG celebrate consecutive Champions League titles after Arsenal collapse

    3 hours ago
  • Revanth Reddy slams Fadnavis over Tummidihatti barrage talks

    3 hours ago
  • BJP launches ‘Brotherhood Program’ to mark 12 years of Modi govt

    4 hours ago
  • IMD forecasts below normal rainfall in 2026

    4 hours ago
  • Hospitals refuse admission to Abhishek Banerjee after attack in Sonarpur

    4 hours ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam